These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 29076002)
21. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
22. Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome. Garrett C; Becker TM; Lynch D; Po J; Xuan W; Scott KF; de Souza P PLoS One; 2021; 16(6):e0252614. PubMed ID: 34138894 [TBL] [Abstract][Full Text] [Related]
23. Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression. McNamara MG; Lwin Z; Jiang H; Templeton AJ; Zadeh G; Bernstein M; Chung C; Millar BA; Laperriere N; Mason WP J Neurooncol; 2014 Mar; 117(1):147-52. PubMed ID: 24469854 [TBL] [Abstract][Full Text] [Related]
24. Analysis of Factors Associated with Long-Term Survival in Patients with Glioblastoma. Madhugiri VS; Moiyadi AV; Shetty P; Gupta T; Epari S; Jalali R; Subeikshanan V; Dutt A; Sasidharan GM; Roopesh Kumar VR; Shankar Ganesh CV; Ramesh AS; Sathia Prabhu A World Neurosurg; 2021 May; 149():e758-e765. PubMed ID: 33540096 [TBL] [Abstract][Full Text] [Related]
25. Systemic Inflammatory Indicators as Prognosticators in Glioblastoma Patients: A Comprehensive Meta-Analysis. Yang C; Wen HB; Zhao YH; Huang WH; Wang ZF; Li ZQ Front Neurol; 2020; 11():580101. PubMed ID: 33117267 [No Abstract] [Full Text] [Related]
26. The global immune-nutrition-inflammation index (GINI) as a robust prognostic factor in glioblastoma patients treated with the standard stupp protocol. Topkan E; Kilic Durankus N; Senyurek S; Öztürk D; Besen AA; Mertsoylu H; Pehlivan B; Selek U Int J Immunopathol Pharmacol; 2024; 38():3946320241284089. PubMed ID: 39305006 [TBL] [Abstract][Full Text] [Related]
27. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
28. Preoperative Neutrophil/Lymphocyte Ratio Is an Independent Prognostic Biomarker in Patients with Low-Grade Gliomas. Tan Z; Shen L; Wu H; Deng L; Li Z; Huang X World Neurosurg; 2019 Dec; 132():e585-e590. PubMed ID: 31442642 [TBL] [Abstract][Full Text] [Related]
29. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M J BUON; 2015; 20(3):714-22. PubMed ID: 26214622 [TBL] [Abstract][Full Text] [Related]
30. Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients. Kaya V; Yıldırım M; Yazıcı G; Yalçın AY; Orhan N; Güzel A Asian Pac J Cancer Prev; 2017 Dec; 18(12):3287-3291. PubMed ID: 29286221 [TBL] [Abstract][Full Text] [Related]
31. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy. Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168 [TBL] [Abstract][Full Text] [Related]
32. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer. Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients. Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479 [TBL] [Abstract][Full Text] [Related]
34. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. Han S; Liu Y; Li Q; Li Z; Hou H; Wu A BMC Cancer; 2015 Sep; 15():617. PubMed ID: 26341881 [TBL] [Abstract][Full Text] [Related]
35. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma. Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669 [TBL] [Abstract][Full Text] [Related]
36. Elevated preoperative neutrophil-to-lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer. Hong J; Mao Y; Chen X; Zhu L; He J; Chen W; Li Y; Lin L; Fei X; Shen K Tumour Biol; 2016 Mar; 37(3):4135-42. PubMed ID: 26490984 [TBL] [Abstract][Full Text] [Related]
37. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor. Kang M; Jeong CW; Kwak C; Kim HH; Ku JH Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452 [TBL] [Abstract][Full Text] [Related]
38. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients. Yaprak M; Turan MN; Dayanan R; Akın S; Değirmen E; Yıldırım M; Turgut F Int Urol Nephrol; 2016 Aug; 48(8):1343-1348. PubMed ID: 27118565 [TBL] [Abstract][Full Text] [Related]
39. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488 [TBL] [Abstract][Full Text] [Related]
40. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors. Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]